Technical Analysis for AVRO - AVROBIO, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.29 | -0.77% | -0.01 |
AVRO closed down 0.77 percent on Monday, March 18, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Mar 21
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Bollinger Band Squeeze | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
BB Squeeze + Lower Band Touch | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -0.77% | |
Pocket Pivot | Bullish Swing Setup | -0.77% | |
Bollinger Band Squeeze | Range Contraction | -0.77% |
Alert | Time |
---|---|
Down 2 % | about 11 hours ago |
Possible NR7 | about 11 hours ago |
Possible Inside Day | about 11 hours ago |
Gap Down Closed | about 12 hours ago |
10 DMA Resistance | about 12 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/21/2024
Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Gene Therapy Virotherapy Medical Genetics Genetic Engineering Gene Delivery
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Rare Diseases Gene Therapy Virotherapy Medical Genetics Genetic Engineering Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.7 |
52 Week Low | 0.57 |
Average Volume | 336,396 |
200-Day Moving Average | 1.38 |
50-Day Moving Average | 1.32 |
20-Day Moving Average | 1.30 |
10-Day Moving Average | 1.30 |
Average True Range | 0.06 |
RSI (14) | 47.09 |
ADX | 38.54 |
+DI | 6.73 |
-DI | 22.15 |
Chandelier Exit (Long, 3 ATRs) | 1.18 |
Chandelier Exit (Short, 3 ATRs) | 1.38 |
Upper Bollinger Bands | 1.33 |
Lower Bollinger Band | 1.27 |
Percent B (%b) | 0.32 |
BandWidth | 4.66 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0009 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.34 | ||||
Resistance 3 (R3) | 1.33 | 1.32 | 1.33 | ||
Resistance 2 (R2) | 1.32 | 1.31 | 1.32 | 1.32 | |
Resistance 1 (R1) | 1.30 | 1.30 | 1.31 | 1.31 | 1.32 |
Pivot Point | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 |
Support 1 (S1) | 1.27 | 1.28 | 1.28 | 1.28 | 1.26 |
Support 2 (S2) | 1.26 | 1.27 | 1.26 | 1.26 | |
Support 3 (S3) | 1.24 | 1.26 | 1.25 | ||
Support 4 (S4) | 1.25 |